VCIM
ZYME icon

Velan Capital Investment Management’s Zymeworks ZYME Stock Holding History

Velan Capital Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-234,902
Closed -$1.45M – 35
2022
Q3 		$1.45M Buy
+234,902
New +$1.42M 1.43% 13

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Velan Capital Investment Management's ZYME Position: Q4 2022 in Review

Velan Capital Investment Management sold out of Zymeworks (ZYME) in Q4 2022, closing a stake of 234,902 shares — an estimated $1.45M sold.

Velan Capital Investment Management first reported a position in ZYME in Q3 2022 and held it in 1 quarter. The position peaked at $1.45M in Q3 2022. 96 funds tracked by Wall St. Rank hold ZYME as of Q4 2022.

  • Velan Capital Investment Management reported no remaining Zymeworks position as of Q4 2022 after selling out during the quarter.
  • Velan Capital Investment Management sold 234,902 Zymeworks shares in Q4 2022, an estimated $1.45M.
  • Velan Capital Investment Management first reported a position in Zymeworks in Q3 2022 and held it in 1 quarter.
  • Velan Capital Investment Management's Zymeworks position peaked at $1.45M in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Zymeworks as of Q4 2022.

Based on Velan Capital Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.